References
- Cancer incidence in Sweden. National Board of Health and Welfare, The Cancer Registry, Stockholm 1984
- Mettlin C, Natarajan N, Mittelman A, et al. Management and survival of adenocarcinoma of the rectum in the United States: results of a national survey by the American College of Surgeons. Oncology 1982; 39: 265–73
- Whittaker M, Goligher J C. The prognosis after surgical treatment for carcinoma of the rectum. Br J Surg 1976; 63: 384–8
- Oncological Centre of the medical service in West Sweden. Activity and cancer statistics in 1960–1980. Onkologiskt centrum, Sahlgrenska sjukhuset, Göteborg, In Swedish
- Holliday H W., Hardcastle J D. Delay in diagnosis and treatment of symptomatic colorectal cancer. Lancet 1979; i: 309–11
- Silverberg E, Holleb A I. Major trends in cancer. 25 year survey. CA 1975; 25: 1–8
- Dickinson J A. Biases in the assessment of colorectal cancer screening programmes using Hemoccult. Aust NZ J Surg 1982; 6: 622–5
- Choung J JH. A screening primer: basic principles, criteria, and pitfalls of screening with comments on colorectal carcinoma. J Clin Gastroenterol 1983; 5: 229–33
- Simon J B. Occult blood screening for colorectal carcinoma: A critical review. Gastroenterology 1985; 88: 820–37
- Jaffe R M, Kasten B, Young D S, et al. False-negative stool occult blood tests caused by ingestion of ascorbic acid (vitamin C). Ann Intern Med 1975; 83: 824–6
- Lifton O, Kreiser J. False-positive stool occult blood tests caused by iron preparations. A controlled study and review of literature. Gastroenterology 1982; 83: 860–3
- Rees W D, Turnberg L A. Reappraisal of the effects of aspirin on the stomach. Lancet 1980; ii: 410–3
- Norfleet R G, Rhodes R A, Saviage K, et al. Falsepositive “Hemoccult” reaction with cimetidine (lett). N Engl J Med 1980; 302: 467
- Songster C L, Barrows G H, Jarret D D. Immunochemical detection of fecal occult blood. Cancer 1980; 45: 1099–1102
- Ribet A, Frexinos J, Escourrou J, et al. Occult blood tests and colorectal tumours. Lancet 1980; i: 417